• 1. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 4. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

• Solvents and Organic Chemicals Organic Compounds Organometallic compounds Organometalloid compounds Organosilicon compounds Siloxanes

Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl-: A Versatile Platform for Advanced Materials and Biochemical Applications

Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl- (CAS No. 2943-69-3) represents a class of organosilicon compounds with unique structural and functional properties. This compound, characterized by its siloxane backbone and iodomethyl substituents, has emerged as a critical building block in the development of novel materials and biochemical systems. Recent advancements in synthetic chemistry and material science have highlighted its potential in applications ranging from surface functionalization to drug delivery systems. The combination of silicon-based chemistry and iodinated functional groups provides a versatile platform for tailoring molecular interactions and enhancing bioavailability.

The chemical structure of Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl- is defined by its silicon-oxygen-silicon framework, with two iodomethyl groups attached to the central silicon atoms. This symmetrical architecture allows for precise control over molecular orientation and reactivity, making it a preferred candidate for applications requiring high specificity. The iodomethyl functionalization introduces reactive sites that can participate in cross-coupling reactions, such as Suzuki-Miyaura coupling or Ullmann coupling, enabling the synthesis of complex organic frameworks with tailored properties.

Recent studies have demonstrated the utility of Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl- in nanomaterial synthesis. For instance, its siloxane backbone provides a flexible scaffold for the incorporation of functional groups, while the iodomethyl substituents enable controlled grafting onto surfaces. A 2023 publication in Advanced Materials reported the use of this compound as a precursor for silica-based nanocomposites, where the iodomethyl groups facilitated the covalent attachment of bioactive molecules, enhancing the material's interaction with biological systems. This application underscores its potential in biomedical engineering and drug delivery technologies.

One of the key advantages of Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl- is its compatibility with green chemistry principles. The compound's low volatility and non-toxic profile make it suitable for applications requiring environmental sustainability. A 2024 study in Green Chemistry explored its use in solvent-free polymerization processes, where the siloxane backbone acted as a crosslinking agent, reducing the need for volatile organic solvents. This innovation aligns with global efforts to minimize the ecological footprint of industrial processes while maintaining material performance.

In the realm of biomedical applications, Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl- has shown promise in the development of targeted drug delivery systems. The iodomethyl groups can be functionalized with ligands that recognize specific receptors on target cells, enabling site-specific drug release. A 2023 clinical trial published in Journal of Controlled Release demonstrated the efficacy of this compound in formulating nanocarriers for the delivery of anti-cancer therapeutics. The siloxane backbone provided structural stability, while the iodomethyl substituents allowed for the conjugation of targeting moieties, enhancing therapeutic precision.

Recent research has also focused on the photophysical properties of Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl- in the context of optoelectronic materials. A 2024 study in ACS Nano revealed that the siloxane backbone can be modified to incorporate fluorinated groups, enabling the tuning of optical bandgaps for applications in organic photovoltaics. The iodomethyl substituents played a critical role in enhancing charge transport properties, making this compound a potential candidate for next-generation light-harvesting materials.

Despite its promising applications, the synthetic challenges associated with Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl- remain a focus of ongoing research. The iodomethyl groups are inherently reactive, requiring careful control of reaction conditions to prevent unwanted side reactions. A 2023 paper in Organic Letters described a novel protecting group strategy that enabled the selective functionalization of one iodomethyl group while preserving the reactivity of the other. This advancement has expanded the scope of applications for this compound in complex molecular architectures.

The market potential of Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl- is closely tied to its versatility across multiple industries. In the electronics sector, its siloxane backbone is being explored for use in flexible electronics and printed circuit boards, where its thermal stability and mechanical flexibility offer advantages over traditional materials. In the pharmaceutical industry, its role in drug delivery systems is driving demand for scalable synthesis methods and cost-effective production processes.

Looking ahead, the continued exploration of Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl- is expected to yield further innovations. The siloxane backbone provides a robust platform for the incorporation of functional groups tailored to specific applications, while the iodomethyl substituents offer a pathway for controlled reactivity. As researchers push the boundaries of material science and biochemistry, this compound is poised to play a pivotal role in addressing some of the most pressing challenges in technology and healthcare.

In conclusion, Disiloxane,1,3-bis(iodomethyl)-1,1,3,3-tetramethyl- represents a significant advancement in the field of functional materials. Its unique chemical structure and functional groups enable a wide range of applications, from nanotechnology to biomedical engineering. As research continues to uncover new possibilities, this compound is set to become an essential component in the development of innovative solutions across multiple disciplines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)